Xarelto in the Prophylaxis of Post Surgical Venous Thromboembolism After Elective Major Orthopedic Surgery of Hip or Knee in Indian Patients
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism
- Focus Adverse reactions
- Acronyms XYRIS
- Sponsors Bayer
- 03 Feb 2016 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 15 Jun 2015 Planned End Date changed from 1 Nov 2014 to 1 Nov 2016, according to ClinicalTrials.gov record.
- 15 Jun 2015 Planned primary completion date changed from 1 Nov 2014 to 1 Nov 2016, according to ClinicalTrials.gov record.